Tag: Innovative Drugs
Han Kun advises 3SBio in landmark Pfizer licensing deal
3SBio inks major licensing deal with Pfizer for cancer drug SSGJ-707
3SBio inks major licensing deal with Pfizer for cancer drug SSGJ-707
For Marco Chung, group head of legal at CITIC Securities International, the choice for arbitration seat in China-related disputes is clear
Paul Chow shares his views on shaping HKEX legal strategy, sustainability leadership and responsible AI use in markets